Skip to main content
logo
Arbutus Biopharma Corporation (ABUS)
NASDAQ: ABUS · Real-Time Price · USD
4.130
-0.040 (-0.96%)
At close: Feb 18, 2026, 4:00 PM EST
4.270
+0.140 (3.38%)
After-hours: Feb 18, 2026, 7:15 PM EST

Arbutus Biopharma Market Cap

Arbutus Biopharma has a market cap or net worth of $794.3 million as of February 18, 2026. Its market cap has increased by 25.88% in one year.

Market Cap
794.30M
Enterprise Value
705.20M
1-Year Change
25.88%
Ranking
#2696
Category
Small-Cap
Stock Price
$4.13

Market Cap Chart

Since December 31, 2009, Arbutus Biopharma's market cap has increased from $47.50M to $794.30M, an increase of 1,572.21%. That is a compound annual growth rate of 19.06%.

History

DateMarket Cap% Change
Feb 17, 2026802.00M-13.31%
Dec 31, 2025925.10M49.31%
Dec 31, 2024619.60M47.81%
Dec 29, 2023419.20M14.98%
Dec 30, 2022364.60M-30.71%
Dec 31, 2021526.20M74.59%
Dec 31, 2020301.40M90.76%
Dec 31, 2019158.00M-25.65%
Dec 31, 2018212.50M-23.56%
Dec 29, 2017278.00M106.85%
Dec 30, 2016134.40M-44.65%
Dec 31, 2015242.80M-28.19%
Dec 31, 2014338.10M196.58%
Dec 31, 2013114.00M89.05%
Dec 31, 201260.30M289.03%
Dec 30, 201115.50M-68.04%
Dec 31, 201048.50M2.11%
Dec 31, 200947.50M-
Dec 31, 200947.50M-
View and export this data all the way back to 2009. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
Janux Therapeutics790.34M
Bicara Therapeutics778.45M
MiMedx Group758.28M
Maravai LifeSciences Holdings756.89M
KalVista Pharmaceuticals753.65M
MapLight Therapeutics751.51M
Arvinas748.21M
AgomAb Therapeutics NV747.62M
Market Cap Rankings